SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-14-068736
Filing Date
2014-11-14
Accepted
2014-11-14 16:01:35
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v393077_10q.htm 10-Q 551054
2 EXHIBIT 10.1 v393077_ex10-1.htm EX-10.1 319368
3 EXHIBIT 31.1 v393077_ex31-1.htm EX-31.1 11960
4 EXHIBIT 31.2 v393077_ex31-2.htm EX-31.2 11550
5 EXHIBIT 32.1 v393077_ex32-1.htm EX-32.1 4487
6 EXHIBIT 32.2 v393077_ex32-2.htm EX-32.2 4329
  Complete submission text file 0001144204-14-068736.txt   5320946

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tgtx-20140930.xml EX-101.INS 688701
8 XBRL TAXONOMY EXTENSION SCHEMA tgtx-20140930.xsd EX-101.SCH 53938
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tgtx-20140930_cal.xml EX-101.CAL 34251
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tgtx-20140930_def.xml EX-101.DEF 275542
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tgtx-20140930_lab.xml EX-101.LAB 360798
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tgtx-20140930_pre.xml EX-101.PRE 316284
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32639 | Film No.: 141223864
SIC: 2834 Pharmaceutical Preparations